2270 related articles for article (PubMed ID: 33789826)
1. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
Int J Surg; 2021 Apr; 88():105906. PubMed ID: 33789826
[TBL] [Abstract][Full Text] [Related]
2. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
J Clin Epidemiol; 2021 Jun; 134():178-189. PubMed ID: 33789819
[TBL] [Abstract][Full Text] [Related]
3. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
Rev Esp Cardiol (Engl Ed); 2021 Sep; 74(9):790-799. PubMed ID: 34446261
[TBL] [Abstract][Full Text] [Related]
4. [The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas].
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
Rev Panam Salud Publica; 2022; 46():e112. PubMed ID: 36601438
[TBL] [Abstract][Full Text] [Related]
5. PRISMA 2020 statement: What's new and the importance of reporting guidelines.
Sohrabi C; Franchi T; Mathew G; Kerwan A; Nicola M; Griffin M; Agha M; Agha R
Int J Surg; 2021 Apr; 88():105918. PubMed ID: 33789825
[TBL] [Abstract][Full Text] [Related]
6. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Moher D
J Clin Epidemiol; 2021 Jun; 134():103-112. PubMed ID: 33577987
[TBL] [Abstract][Full Text] [Related]
7. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer's disease before and after PRISMA introduction.
Sun X; Zhou X; Yu Y; Liu H
BMC Med Res Methodol; 2018 Nov; 18(1):154. PubMed ID: 30497417
[TBL] [Abstract][Full Text] [Related]
8. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
[TBL] [Abstract][Full Text] [Related]
9. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
[TBL] [Abstract][Full Text] [Related]
10. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review.
Page MJ; Moher D
Syst Rev; 2017 Dec; 6(1):263. PubMed ID: 29258593
[TBL] [Abstract][Full Text] [Related]
11. Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines.
Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann T; Mulrow CD; Shamseer L; Moher D
J Clin Epidemiol; 2020 Feb; 118():60-68. PubMed ID: 31740319
[TBL] [Abstract][Full Text] [Related]
12. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
[TBL] [Abstract][Full Text] [Related]
13. Quality of reporting of systematic reviews and meta-analyses in emergency medicine based on the PRISMA statement.
Nawijn F; Ham WHW; Houwert RM; Groenwold RHH; Hietbrink F; Smeeing DPJ
BMC Emerg Med; 2019 Feb; 19(1):19. PubMed ID: 30744570
[TBL] [Abstract][Full Text] [Related]
14. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
[TBL] [Abstract][Full Text] [Related]
15. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
[TBL] [Abstract][Full Text] [Related]
16. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
[TBL] [Abstract][Full Text] [Related]
17. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
[TBL] [Abstract][Full Text] [Related]
18. Reporting and Methodological Quality of Systematic Reviews and Meta-Analyses of Nursing Interventions in Patients With Alzheimer's Disease: General Implications of the Findings.
Sun X; Zhou X; Zhang Y; Liu H
J Nurs Scholarsh; 2019 May; 51(3):308-316. PubMed ID: 30806019
[TBL] [Abstract][Full Text] [Related]
19. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Shamseer L; Moher D; Clarke M; Ghersi D; Liberati A; Petticrew M; Shekelle P; Stewart LA;
BMJ; 2015 Jan; 350():g7647. PubMed ID: 25555855
[TBL] [Abstract][Full Text] [Related]
20. [Introduction to PRISMA-CI extension statement and checklist systematic reviews on complex interventions].
Zhang G; Wang WW; Yang ZR; Zhan SY; Sun F
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jul; 40(7):832-838. PubMed ID: 31357807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
